Market cap
₹22 Cr
Revenue (TTM)
₹366 Cr
P/E Ratio
--
P/B Ratio
0.2
Div. Yield
0 %
| Welcure Drugs | Entero Health | Bio Medica Laboratories | Speciality Medicines | VijayPD Ceutical | |
|---|---|---|---|---|---|
Market cap (₹ Cr) |
22 | 8,646 | 186 | 134 | 121 |
Revenue (₹ Cr) |
366 | 7,644 | 43 | 75 | 100 |
Net Profit (₹ Cr) |
-16.99 | 191.80 | 11.89 | 13.03 | 5.00 |
Net Margin (%) |
-4.63 | 2.50 | 27.57 | 17.12 | 4.79 |
RoE (%) |
-14.35 | 8.35 | 57.64 | 25.60 | 9.53 |
Price to Earnings |
-- | 62.04 | 15.82 | 10.31 | 24.25 |
Price-To-Book |
0.23 | 4.87 | 2.53 | 1.89 | 2.31 |
Income Statement (₹ Cr)
| Welcure Drugs | Entero Health | Bio Medica Laboratories | Speciality Medicines | VijayPD Ceutical | |
|---|---|---|---|---|---|
|
Operating Revenue
|
24.55 | 5,095.78 | 38.32 | 58.27 | 100.23 |
|
Total Income
|
26.46 | 5,135.29 | 38.33 | 58.54 | 100.98 |
|
Total Expenditure
|
23.58 | 4,924.23 | 22.82 | 49.14 | 91.81 |
|
EBITDA
|
0.97 | 171.55 | 15.50 | 9.13 | 8.42 |
|
Depreciation
|
0.01 | 30.69 | 1.01 | 0.20 | 0.62 |
|
EBIT
|
0.96 | 140.86 | 14.49 | 8.93 | 7.80 |
|
Interest
|
0.09 | 41.62 | 1.35 | 0.51 | 2.15 |
|
Other Income
|
1.91 | 39.51 | 0.01 | 0.27 | 0.75 |
|
Exceptional Items
|
-- | -- | -- | -- | -- |
|
Profit before Tax
|
2.78 | 138.74 | 13.14 | 8.69 | 6.40 |
|
Provision for Tax
|
0.61 | 31.31 | 3.44 | 1.49 | 1.69 |
|
Profit after Tax
|
2.17 | 107.43 | 9.70 | 7.20 | 4.71 |
Liabilities (₹ Cr)
| Welcure Drugs | Entero Health | Bio Medica Laboratories | Speciality Medicines | VijayPD Ceutical | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
102.51 | 1,724.15 | 14.73 | 30.62 | 32.42 |
|
Minority Interest
|
-- | 46.21 | -- | -- | -- |
|
Non-Current Liabilities
|
123.20 | 72.84 | 10.51 | 2.78 | 0.53 |
|
Current Liabilities
|
41.27 | 845.02 | 13.26 | 6.62 | 24.31 |
|
Total Liabilities
|
266.98 | 2,702.52 | 38.70 | 40.01 | 57.28 |
Assets (₹ Cr)
| Welcure Drugs | Entero Health | Bio Medica Laboratories | Speciality Medicines | VijayPD Ceutical | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
84.84 | 612.51 | 7.85 | 3.59 | 11.00 |
|
Current Assets
|
182.14 | 2,075.71 | 30.65 | 36.42 | 46.26 |
|
Total Assets
|
266.98 | 2,702.52 | 38.70 | 40.01 | 57.28 |
|
Total Debt*
|
123.20 | 298.81 | 15.01 | 5.05 | 21.77 |
|
Net Current Assets
|
140.87 | 1,230.69 | 17.39 | 29.80 | 21.95 |
|
Contingent Liabilities
|
-- | 4.01 | 0.05 | -- | 0.05 |
Cashflow (₹ Cr)
| Welcure Drugs | Entero Health | Bio Medica Laboratories | Speciality Medicines | VijayPD Ceutical | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
-222.03 | -76.87 | -4.57 | -6.43 | -34.50 |
|
Cash Flow from Investing Activities
|
-0.06 | 219.80 | 0.05 | -1.43 | -9.72 |
|
Cash from Financing Activities
|
222.20 | -73.66 | 4.52 | 8.46 | 47.32 |
|
Net Cash Inflow / Outflow
|
0.11 | 69.27 | 0.00 | 0.60 | 3.10 |
Ratios
Profitability Ratios
| Welcure Drugs | Entero Health | Bio Medica Laboratories | Speciality Medicines | VijayPD Ceutical | |
|---|---|---|---|---|---|
|
ROCE (%)
|
2.53 | 9.16 | 48.73 | 34.34 | 15.78 |
|
ROE (%)
|
4.18 | 6.40 | 65.87 | 31.50 | 14.53 |
|
ROA (%)
|
1.62 | 4.29 | 25.20 | 22.97 | 8.23 |
|
EBIT Margin (%)
|
11.72 | 4.14 | 40.46 | 16.13 | 9.15 |
|
Net Margin (%)
|
8.20 | 2.09 | 25.32 | 12.29 | 4.66 |
|
Cash Profit Margin (%)
|
8.87 | 2.71 | 27.95 | 12.69 | 5.32 |
Growth Ratios
| Welcure Drugs | Entero Health | Bio Medica Laboratories | Speciality Medicines | VijayPD Ceutical | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
-- | 29.92 | 0.00 | 111.71 | 0.00 |
|
EBIT Growth (%)
|
2,172.91 | 67.16 | 232.68 | 73.88 | -- |
|
Net Profit Growth (%)
|
1,341.48 | 169.94 | 0.00 | 145.30 | 0.00 |
|
EPS Growth (%)
|
248.31 | 142.37 | 0.00 | 95.03 | 0.00 |
|
Book Value Growth (%)
|
7,547.19 | 5.11 | 0.00 | 103.28 | 0.00 |
Valuation Ratios
| Welcure Drugs | Entero Health | Bio Medica Laboratories | Speciality Medicines | VijayPD Ceutical | |
|---|---|---|---|---|---|
|
Price / Earnings
|
4.28 | 52.15 | 0.00 | 0.00 | 0.00 |
|
Price / Book Value
|
1.00 | 2.88 | 0.00 | 0.00 | 0.00 |
|
Dividend Yield (%)
|
0.00 | 0.00 | -- | -- | -- |
|
EV/EBITDA
|
78.30 | 23.61 | 1.56 | 1.13 | 3.57 |
|
Market Cap (₹ Cr)
|
102.21 | 4,944.94 | 0.00 | 0.00 | 0.00 |
Solvency Ratios
| Welcure Drugs | Entero Health | Bio Medica Laboratories | Speciality Medicines | VijayPD Ceutical | |
|---|---|---|---|---|---|
|
Debt to Equity
|
1.20 | 0.17 | 1.02 | 0.16 | 0.67 |
|
Short term debt to equity ratio
|
-- | 0.17 | 0.21 | 0.04 | 0.63 |
|
Current Ratio
|
4.41 | 2.46 | 2.31 | 5.50 | 1.90 |
|
Quick Ratio
|
0.94 | 1.68 | 0.94 | 2.88 | 1.43 |
|
Interest Coverage
|
32.06 | 4.33 | 10.71 | 18.03 | 3.97 |
Operating Efficiency Ratios
| Welcure Drugs | Entero Health | Bio Medica Laboratories | Speciality Medicines | VijayPD Ceutical | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
77.19 | 16.30 | 10.70 | 16.48 | 23.74 |
|
Asset Turnover
|
0.18 | 2.03 | 1.00 | 1.86 | 1.75 |
|
Receivable days
|
281.74 | 51.78 | 39.05 | 63.63 | 86.66 |
|
Inventory Days
|
2,133.85 | 38.71 | 172.77 | 79.57 | 42.01 |
|
Payable days
|
51.58 | 24.83 | 159.82 | 14.65 | 8.08 |
|
Cash Conversion Cycle
|
2,364.01 | 65.66 | 52.00 | 128.55 | 120.60 |